Global Percutaneous Transluminal Angioplasty Instrument Market Research Report 2025(Status and Outlook)

March 2025 | 139 pages | ID: G0C9BCF18731EN
Bosson Research

Abstracts

Report Overview

Percutaneous Transluminal Angioplasty (PTA) instruments are medical devices used in minimally invasive procedures to open blocked or narrowed blood vessels. These instruments typically consist of a balloon catheter that is inserted into the blood vessel and inflated to widen the vessel lumen, restoring blood flow. PTA instruments are commonly used in the treatment of various vascular conditions, such as peripheral artery disease and coronary artery disease. The market for PTA instruments is driven by the increasing prevalence of cardiovascular diseases, technological advancements in minimally invasive procedures, and the growing demand for outpatient treatments. Additionally, the rising geriatric population and the increasing adoption of unhealthy lifestyles leading to vascular diseases are further fueling the demand for PTA instruments.

Market trends in the PTA instrument industry include the development of advanced balloon materials and coatings to improve efficacy and reduce complications, the integration of imaging technologies for better visualization during procedures, and the introduction of drug-coated balloons for targeted drug delivery. Moreover, there is a growing trend towards the use of PTA instruments in combination with other minimally invasive techniques, such as stenting, to achieve better treatment outcomes. The market is also witnessing an increasing focus on training and education programs for healthcare professionals to enhance their skills in performing PTA procedures. Overall, the PTA instrument market is expected to continue growing as the prevalence of vascular diseases rises globally and as technological innovations drive improvements in treatment outcomes.

This report provides a deep insight into the global Percutaneous Transluminal Angioplasty Instrument market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Percutaneous Transluminal Angioplasty Instrument Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Percutaneous Transluminal Angioplasty Instrument market in any manner.

Global Percutaneous Transluminal Angioplasty Instrument Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott

Boston Scientific

Medtronic

Terumo Medical

Lepu Medical

MicroPort

Biosensors

B.Braun

Atrium Medical

Biotronik

Asahi Intecc

Cardinal

Integer

Cook Medical

TE Connectivity

Merit

SP Medical

Market Segmentation (by Type)

Introducer

Angiographic Catheter

Balloon Catheter

Guide Wire

Stent

Others

Market Segmentation (by Application)

Below 40 Years Old

40 ~ 60 Years Old

Above 60 Years Old

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Percutaneous Transluminal Angioplasty Instrument Market
• Overview of the regional outlook of the Percutaneous Transluminal Angioplasty Instrument Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Percutaneous Transluminal Angioplasty Instrument Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Percutaneous Transluminal Angioplasty Instrument
1.2 Key Market Segments
1.2.1 Percutaneous Transluminal Angioplasty Instrument Segment by Type
1.2.2 Percutaneous Transluminal Angioplasty Instrument Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Percutaneous Transluminal Angioplasty Instrument Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Percutaneous Transluminal Angioplasty Instrument Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Percutaneous Transluminal Angioplasty Instrument Product Life Cycle
3.3 Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Company (2020-2025)
3.4 Percutaneous Transluminal Angioplasty Instrument Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Percutaneous Transluminal Angioplasty Instrument Company Headquarters, Area Served, Product Type
3.6 Percutaneous Transluminal Angioplasty Instrument Market Competitive Situation and Trends
3.6.1 Percutaneous Transluminal Angioplasty Instrument Market Concentration Rate
3.6.2 Global 5 and 10 Largest Percutaneous Transluminal Angioplasty Instrument Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Percutaneous Transluminal Angioplasty Instrument Value Chain Analysis
4.1 Percutaneous Transluminal Angioplasty Instrument Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Percutaneous Transluminal Angioplasty Instrument Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Percutaneous Transluminal Angioplasty Instrument Market Porter's Five Forces Analysis
6 Percutaneous Transluminal Angioplasty Instrument Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Percutaneous Transluminal Angioplasty Instrument Market Size Market Share by Type (2020-2025)
6.3 Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Type (2021-2025)
7 Percutaneous Transluminal Angioplasty Instrument Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Percutaneous Transluminal Angioplasty Instrument Market Size (M USD) by Application (2020-2025)
7.3 Global Percutaneous Transluminal Angioplasty Instrument Sales Growth Rate by Application (2020-2025)
8 Percutaneous Transluminal Angioplasty Instrument Market Segmentation by Region
8.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region
8.1.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region
8.1.2 Global Percutaneous Transluminal Angioplasty Instrument Market Size Market Share by Region
8.2 North America
8.2.1 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Percutaneous Transluminal Angioplasty Instrument Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Percutaneous Transluminal Angioplasty Instrument Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbott
9.1.1 Abbott Basic Information
9.1.2 Abbott Percutaneous Transluminal Angioplasty Instrument Product Overview
9.1.3 Abbott Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.1.4 Abbott SWOT Analysis
9.1.5 Abbott Business Overview
9.1.6 Abbott Recent Developments
9.2 Boston Scientific
9.2.1 Boston Scientific Basic Information
9.2.2 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Overview
9.2.3 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.2.4 Boston Scientific SWOT Analysis
9.2.5 Boston Scientific Business Overview
9.2.6 Boston Scientific Recent Developments
9.3 Medtronic
9.3.1 Medtronic Basic Information
9.3.2 Medtronic Percutaneous Transluminal Angioplasty Instrument Product Overview
9.3.3 Medtronic Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.3.4 Medtronic SWOT Analysis
9.3.5 Medtronic Business Overview
9.3.6 Medtronic Recent Developments
9.4 Terumo Medical
9.4.1 Terumo Medical Basic Information
9.4.2 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Overview
9.4.3 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.4.4 Terumo Medical Business Overview
9.4.5 Terumo Medical Recent Developments
9.5 Lepu Medical
9.5.1 Lepu Medical Basic Information
9.5.2 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Overview
9.5.3 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.5.4 Lepu Medical Business Overview
9.5.5 Lepu Medical Recent Developments
9.6 MicroPort
9.6.1 MicroPort Basic Information
9.6.2 MicroPort Percutaneous Transluminal Angioplasty Instrument Product Overview
9.6.3 MicroPort Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.6.4 MicroPort Business Overview
9.6.5 MicroPort Recent Developments
9.7 Biosensors
9.7.1 Biosensors Basic Information
9.7.2 Biosensors Percutaneous Transluminal Angioplasty Instrument Product Overview
9.7.3 Biosensors Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.7.4 Biosensors Business Overview
9.7.5 Biosensors Recent Developments
9.8 B.Braun
9.8.1 B.Braun Basic Information
9.8.2 B.Braun Percutaneous Transluminal Angioplasty Instrument Product Overview
9.8.3 B.Braun Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.8.4 B.Braun Business Overview
9.8.5 B.Braun Recent Developments
9.9 Atrium Medical
9.9.1 Atrium Medical Basic Information
9.9.2 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Overview
9.9.3 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.9.4 Atrium Medical Business Overview
9.9.5 Atrium Medical Recent Developments
9.10 Biotronik
9.10.1 Biotronik Basic Information
9.10.2 Biotronik Percutaneous Transluminal Angioplasty Instrument Product Overview
9.10.3 Biotronik Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.10.4 Biotronik Business Overview
9.10.5 Biotronik Recent Developments
9.11 Asahi Intecc
9.11.1 Asahi Intecc Basic Information
9.11.2 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Overview
9.11.3 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.11.4 Asahi Intecc Business Overview
9.11.5 Asahi Intecc Recent Developments
9.12 Cardinal
9.12.1 Cardinal Basic Information
9.12.2 Cardinal Percutaneous Transluminal Angioplasty Instrument Product Overview
9.12.3 Cardinal Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.12.4 Cardinal Business Overview
9.12.5 Cardinal Recent Developments
9.13 Integer
9.13.1 Integer Basic Information
9.13.2 Integer Percutaneous Transluminal Angioplasty Instrument Product Overview
9.13.3 Integer Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.13.4 Integer Business Overview
9.13.5 Integer Recent Developments
9.14 Cook Medical
9.14.1 Cook Medical Basic Information
9.14.2 Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Overview
9.14.3 Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.14.4 Cook Medical Business Overview
9.14.5 Cook Medical Recent Developments
9.15 TE Connectivity
9.15.1 TE Connectivity Basic Information
9.15.2 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Overview
9.15.3 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.15.4 TE Connectivity Business Overview
9.15.5 TE Connectivity Recent Developments
9.16 Merit
9.16.1 Merit Basic Information
9.16.2 Merit Percutaneous Transluminal Angioplasty Instrument Product Overview
9.16.3 Merit Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.16.4 Merit Business Overview
9.16.5 Merit Recent Developments
9.17 SP Medical
9.17.1 SP Medical Basic Information
9.17.2 SP Medical Percutaneous Transluminal Angioplasty Instrument Product Overview
9.17.3 SP Medical Percutaneous Transluminal Angioplasty Instrument Product Market Performance
9.17.4 SP Medical Business Overview
9.17.5 SP Medical Recent Developments
10 Percutaneous Transluminal Angioplasty Instrument Market Forecast by Region
10.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size Forecast
10.2 Global Percutaneous Transluminal Angioplasty Instrument Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country
10.2.3 Asia Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Region
10.2.4 South America Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Percutaneous Transluminal Angioplasty Instrument by Country
11 Forecast Market by Type and by Application (2026-2033)
11.1 Global Percutaneous Transluminal Angioplasty Instrument Market Forecast by Type (2026-2033)
11.2 Global Percutaneous Transluminal Angioplasty Instrument Market Forecast by Application (2026-2033)
12 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Percutaneous Transluminal Angioplasty Instrument Market Size Comparison by Region (M USD)
Table 5. Global Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) by Company (2020-2025)
Table 6. Global Percutaneous Transluminal Angioplasty Instrument Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Transluminal Angioplasty Instrument as of 2024)
Table 8. Percutaneous Transluminal Angioplasty Instrument Company Headquarters and Area Served
Table 9. Company Percutaneous Transluminal Angioplasty Instrument Product Type
Table 10. Global Percutaneous Transluminal Angioplasty Instrument Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Percutaneous Transluminal Angioplasty Instrument Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Type (M USD)
Table 21. Global Percutaneous Transluminal Angioplasty Instrument Market Size (M USD) by Type (2020-2025)
Table 22. Global Percutaneous Transluminal Angioplasty Instrument Market Size Share by Type (2020-2025)
Table 23. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Type (2021-2025)
Table 24. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application
Table 25. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2020-2025) & (M USD)
Table 26. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2020-2025)
Table 27. Global Percutaneous Transluminal Angioplasty Instrument Sales Growth Rate by Application (2020-2025)
Table 28. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2020-2025) & (M USD)
Table 29. Global Percutaneous Transluminal Angioplasty Instrument Market Size Market Share by Region (2020-2025)
Table 30. North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2020-2025) & (M USD)
Table 33. South America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2020-2025) & (M USD)
Table 35. Abbott Basic Information
Table 36. Abbott Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 37. Abbott Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Abbott SWOT Analysis
Table 39. Abbott Business Overview
Table 40. Abbott Recent Developments
Table 41. Boston Scientific Basic Information
Table 42. Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 43. Boston Scientific Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Boston Scientific SWOT Analysis
Table 45. Boston Scientific Business Overview
Table 46. Boston Scientific Recent Developments
Table 47. Medtronic Basic Information
Table 48. Medtronic Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 49. Medtronic Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Medtronic SWOT Analysis
Table 51. Medtronic Business Overview
Table 52. Medtronic Recent Developments
Table 53. Terumo Medical Basic Information
Table 54. Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 55. Terumo Medical Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 56. Terumo Medical Business Overview
Table 57. Terumo Medical Recent Developments
Table 58. Lepu Medical Basic Information
Table 59. Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 60. Lepu Medical Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Lepu Medical Business Overview
Table 62. Lepu Medical Recent Developments
Table 63. MicroPort Basic Information
Table 64. MicroPort Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 65. MicroPort Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 66. MicroPort Business Overview
Table 67. MicroPort Recent Developments
Table 68. Biosensors Basic Information
Table 69. Biosensors Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 70. Biosensors Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Biosensors Business Overview
Table 72. Biosensors Recent Developments
Table 73. B.Braun Basic Information
Table 74. B.Braun Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 75. B.Braun Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 76. B.Braun Business Overview
Table 77. B.Braun Recent Developments
Table 78. Atrium Medical Basic Information
Table 79. Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 80. Atrium Medical Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Atrium Medical Business Overview
Table 82. Atrium Medical Recent Developments
Table 83. Biotronik Basic Information
Table 84. Biotronik Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 85. Biotronik Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Biotronik Business Overview
Table 87. Biotronik Recent Developments
Table 88. Asahi Intecc Basic Information
Table 89. Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 90. Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 91. Asahi Intecc Business Overview
Table 92. Asahi Intecc Recent Developments
Table 93. Cardinal Basic Information
Table 94. Cardinal Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 95. Cardinal Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Cardinal Business Overview
Table 97. Cardinal Recent Developments
Table 98. Integer Basic Information
Table 99. Integer Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 100. Integer Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Integer Business Overview
Table 102. Integer Recent Developments
Table 103. Cook Medical Basic Information
Table 104. Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 105. Cook Medical Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Cook Medical Business Overview
Table 107. Cook Medical Recent Developments
Table 108. TE Connectivity Basic Information
Table 109. TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 110. TE Connectivity Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 111. TE Connectivity Business Overview
Table 112. TE Connectivity Recent Developments
Table 113. Merit Basic Information
Table 114. Merit Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 115. Merit Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Merit Business Overview
Table 117. Merit Recent Developments
Table 118. SP Medical Basic Information
Table 119. SP Medical Percutaneous Transluminal Angioplasty Instrument Product Overview
Table 120. SP Medical Percutaneous Transluminal Angioplasty Instrument Revenue (M USD) and Gross Margin (2020-2025)
Table 121. SP Medical Business Overview
Table 122. SP Medical Recent Developments
Table 123. Global Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Region (2026-2033) & (M USD)
Table 124. North America Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2026-2033) & (M USD)
Table 125. Europe Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Asia Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Region (2026-2033) & (M USD)
Table 127. South America Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Country (2026-2033) & (M USD)
Table 129. Global Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Type (2026-2033) & (M USD)
Table 130. Global Percutaneous Transluminal Angioplasty Instrument Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Industry Chain of Percutaneous Transluminal Angioplasty Instrument
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Percutaneous Transluminal Angioplasty Instrument Market Size (M USD), 2024-2033
Figure 5. Global Percutaneous Transluminal Angioplasty Instrument Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Percutaneous Transluminal Angioplasty Instrument Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Percutaneous Transluminal Angioplasty Instrument Product Life Cycle
Figure 12. Global Percutaneous Transluminal Angioplasty Instrument Revenue Share by Company in 2024
Figure 13. Percutaneous Transluminal Angioplasty Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Percutaneous Transluminal Angioplasty Instrument Revenue in 2024
Figure 15. Value Chain Map of Percutaneous Transluminal Angioplasty Instrument
Figure 16. Global Percutaneous Transluminal Angioplasty Instrument Market PEST Analysis
Figure 17. Global Percutaneous Transluminal Angioplasty Instrument Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Type
Figure 20. Market Size Share of Percutaneous Transluminal Angioplasty Instrument by Type (2020-2025)
Figure 21. Market Size Share of Percutaneous Transluminal Angioplasty Instrument by Type in 2024
Figure 22. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Application
Figure 25. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2020-2025)
Figure 26. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Application in 2024
Figure 27. Global Percutaneous Transluminal Angioplasty Instrument Sales Growth Rate by Application (2020-2025)
Figure 28. Global Percutaneous Transluminal Angioplasty Instrument Market Size Market Share by Region (2020-2025)
Figure 29. North America Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Percutaneous Transluminal Angioplasty Instrument Market Size Market Share by Country in 2024
Figure 31. U.S. Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Percutaneous Transluminal Angioplasty Instrument Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Percutaneous Transluminal Angioplasty Instrument Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Percutaneous Transluminal Angioplasty Instrument Market Share by Country in 2024
Figure 36. Germany Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Percutaneous Transluminal Angioplasty Instrument Market Size Market Share by Region in 2024
Figure 43. China Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (M USD)
Figure 49. South America Percutaneous Transluminal Angioplasty Instrument Market Size Market Share by Country in 2024
Figure 50. Brazil Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Percutaneous Transluminal Angioplasty Instrument Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Percutaneous Transluminal Angioplasty Instrument Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Percutaneous Transluminal Angioplasty Instrument Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Percutaneous Transluminal Angioplasty Instrument Market Share Forecast by Type (2026-2033)
Figure 62. Global Percutaneous Transluminal Angioplasty Instrument Market Share Forecast by Application (2026-2033)